VNDA Competitors
Vanda Pharmaceuticals Inc.
$4.08
-$0.01(-0.24%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$246.72M
Volume
1.38M
52W Range
$3.57 - $9.94
Target Price
$11.50
VNDA competitors: NVS, LLY, JNJ, BMY, PFE. Vanda Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
VNDA Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| NVS Novartis AG | $163.57 | $312.35B | $9.04 | 2.92% | 68 |
| LLY Eli Lilly and Company | $1434.59 | $1.33T | $35.35 | 0.47% | 69 |
| JNJ Johnson & Johnson | $280.32 | $679.13B | $11.12 | 1.88% | 70 |
| BMY Bristol-Myers Squibb Company | $62.49 | $127.02B | $6.44 | 4.03% | 69 |
| PFE Pfizer Inc. | $29.35 | $166.61B | $3.04 | 4.40% | 74 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VNDA | $4.08 | -0.2% | 1.38M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vanda Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW